The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I see all sides of the story Potnak.
Risk v reward.
If no one took part in WRAP equity raise it would go bust.
What l have paid is my decision, not yours, if you want to choose to pick holes in it then not a lot l can say.
Why have investors already here raised 1.2 million via WRAP?
You going to attempt to pick holes in them?
Regards
All l am asking Potnak is where would the company be with no funding gained from the issue of further shares?
What us wrong with that.
I have contributed to both buying shares snd taking part in the WRAP equity raise.
Yet you try and make put that l am wrong to do this.
I can't work you out Potnak one minute positive the next negative.
1 to 2 million valuation then moaning about dilution.
I will ask again.
WHERE WOULD WE BE WITHOUT THE CURRENT FUND RAISE?
Regards
Exactly!
Tt why the chat board here has suffered an in flux of self righteous mongs here telling us how bad the supposed rampers are.
People don't help by jumping to their cause with their need a balance of negative input. These fools give them the very ammunition they need and will take over like a disease that 737 is designed to treat.
Most have been kicked out. One reckons he should have a statue put up for him.
Can't see a pornagraphic item being put up in public as council not allow it.
Most end up on the ADVN board with absolutely nothing of any substance.
Those that look forward to some here losing money and and aiming insults.
If they want to debate here and have credibility then they are welcome to debate.
Why were they removed?
They are here to help people to save them money?
You are insulted if you do not agree with them.
They also advise you to sell!
Board will slowly come back to normal as dill the Sp rise.
We are 2.5% of the value of what we were 3 years ago but much further forward.
Regards
I bought 90 k shares from Wrap at 10p each.
Now that is on tip of a further 100k bought since last Sept
How is my shareholder value deceased by 30% should the SP reach a modest 100p?
You can dit here and buy shares all day long from the markets and it will.not put a penny in the coffers of Sareum to enable continuation of development.
The over drop in SP l have taken as an opportunity to add considerably.
Not finished adding yet.
No more drawdowns from Riverfort.
PH and RF neither have Sareums interests or ever have done.
Regards
A rough outline in link below.
https://www.linkedin.com/pulse/how-much-does-oncology-clinical-trial-cost-patricio-ledesma#:~:text=As%20general%20rule%20of%20thumb,20%20million%20respectively%20%5B1%5D.
Depends on volume of patients involved.
Approx average cost per patient around 40k.
Phase 2a may only need utilise 10 to 40 patients but will provide proof of concept.
Phase 2 in its entirety and you will be looking at well over a hundred possibly 300 patients.
If we take 25 as an example that would equate to 1 million pound,
Should we take 200 that would equate to 8 million.
There will also be added fees of Clinical trial organisations, expenses and z myriad of other fees at the very least likely to total 1 million on its own.
As Damion says the likelihood we will either be in a partnership or on licence.
Ideally we enter into 2a and then trial size can then be increased.
Whether they wish to carry out in Oz or here l have no idea there are advantages on both sides.
Regards
This share price at the moment is approx 97.5% down from it high 3 years ago.
Increase of 40 fold to bring it back.
1801 progressing well and coming to completion of Phase1a.
News ought to be due soon on 737 with regards to development ie signing of licence.
Much further forward@ Madness.
Regards
Afternoon Potnak, l for one do not think.it is a good thing to have to keep the tax man happy.
Fortunately the threshold has been raised for 24 25 tax year whereby need to complete tax assessment form. However the tax paid is still horrendous along with NI contributions.
Slightly akin to Tim.saying they were having diffuculty reaching an MTD ( they never reached it) Look at the problems that arise later on.
Tax man wants to know in and outs of everything.
The only thing similar in complexity is renewing SC clearance, 38 pages to complete of which all can be checked out if they fo wish.
New Tax year starts soon so lots of bed and ISA transaction l reckon.
Regards
Rayboy, it will return to above that level and considerably more if all goes well.
Once data analysed and satisfactory results obtained price will fly.
The uneducated doubters will state that price has fallen because no one is interested in investing.
Conversely, at some stage you will have interested parties clamouring all over us.
At what point does a 20 million pound compound become a billion pound compound?
Once it's commercial potential is realised and that requires more satisfactory data, than we will have at end of phase 1a.
Phase2 a data may very well achieve this level,
Psoriasis is one indication that should allow us into commercialisation.
Funds have been raised and will tide us over for an important period in the company
Regards
Long read in link below very relevant.
Interesting of molecule size of our competitors.
Fairly recent at end of 2023.
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00406-1/fulltext
Alliance News) - S-Ventures PLC on Friday agreed to sell its operating subsidiaries to RiverFort Global Opportunities PLC, in a deal which gives the former access to the AIM market, and the latter a chance to stem a "weak share price performance".
RiverFort will acquire the assets and liabilities of S-Ventures in a deal valued at GBP3.5 million. RiverFort will issue shares to S-Ventures in exchange and the deal will constitute a reverse takeover. RiverFort shares were suspended as a result.
Riverfort have had suspension since 22nd March.
https://www.lse.co.uk/rns/RGO/suspension-riverfort-global-opportunities-plc-psk0c3aze01ib0m.html
Regards
Good morning Lazarus2
As much as l.understand that informal discussions are that and nothing else, informal discussions must lead to decisions being made by Sareum ie which route they take.
As yet we have not received the crucial phase1a data and to this importantly neither have interested parties.
Recent RNS's lack clarification as with mention of their intent. Phase 2a to enter into is costly but will carry more weight than phase 1a.
Do we have current finance ability to enter phase2a?
Why have a recent change of direction from 1a to 2a if not a result of informal discussion?
To enter into phase 2 is a considerable milestone achievement that will add value to 1801.
Of course cannot enter Phase 2a until full satisfactory results achieved.
Regards
Are we on the submission of phase1a data results to interested party or parties expecting a formal offer or offers to be made?
The continuation of development of SDC1802 indicated in the RNS would suggest along the lines of the above.
Open to discussion here.
Regards
'Post period end, the Company is today announcing a conditional equity fundraise of up to £1.5m (before expenses), via the issue of a total of up to 15,000,000 new ordinary shares of 1.25 pence each in the capital of the Company ("Ordinary Shares") at a price of 10 pence per new Ordinary Share (the "Placing Price") (the "Fundraise").
From the above extract of Sareums recently released RNS questions arise.
The original target of 1.5 million to be raised by share equity has nearly been reached by WRAP offer, in this case are the company seeking to pursue the target of 1.5 million via share equity or still intent on raising 1.2 million pound by the issue of a further 12 million shares?
Are we going to continue in Oz with 1b or are we going to instigate phase2a trials and if so and where with an anticipated time scale?
How are we developing in discussions with interested parties, ie informal discussion at the moment leading to formal communications on receipt of phase 1a data?